Abstract
Expectancy and learning are the core psychological mechanisms of placebo analgesia. They interact with further psychological processes such as emotions and motivations (e.g., anxiety, desire for relief), somatic focus, or cognitions (e.g., attitudes toward the treatment). The development of placebo responsiveness and the actual placebo response in a person is the result of the complex interaction between factors traced back to the individual learning history related to analgesic drugs or treatments and factors of the current context referring to the analgesic or placebo treatment. The aim of this chapter is to depict these complex interactions in a new model of analgesic placebo effects. It joins aspects of the learning history (preexisting experiences and preexisting expectations) of a patient with aspects of the current context (current expectation as a result of external and internal situation in which a pain medication/treatment/placebo is taken, e.g., current information about pain medication, current specific context/cues, desire for pain relief, certainty about upcoming pain relief, current expectation about pain reducing course, current selective attention, increased pain experience, or decreased pain experience). In order to exploit placebo efficacy for an analgesic treatment it is worthwhile to assess in which direction each of these factors exerts its influence in order to maximize placebo effects for a specific patient. By applying placebo mechanisms in this differentiated way, the efficacy of pain treatment can be deliberately boosted.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ader R (1993) Conditioned responses in pharmacotherapy research. Psychol Med 23(2):297–299
Aldrich S, Eccleston C, Crombez G (2000) Worrying about chronic pain: vigilance to threat and misdirected problem solving. Behav Res Ther 38(5):457–470
Basbaum AI, Fields HL (1978) Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 4(5):451–462. doi:10.1002/ana.410040511
Benedetti F, Arduino C, Amanzio M (1999) Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci 19(9):3639–3648
Benedetti F, Maggi G, Lopiano L, Lanotte M, Rainerao I, Vighetti S (2003) Open versus hidden medical treatments: the patient’s knowledge about therapy affects the therapy outcome. Prevention Treatment. doi:10.1037/1522-3736.6.1.61a
Benedetti F, Amanzio M, Rosato R, Blanchard C (2011) Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 17(10):1228–1230. doi:10.1038/nm.2435
Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C (2006) Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120(1–2):8–15. doi:10.1016/j.pain.2005.08.027
Chung H, Lee H, Chang DS, Kim HS, Lee H, Park HJ et al (2012) Doctor’s attire influences perceived empathy in the patient-doctor relationship. Patient Educ Couns 89(3):387–391. doi:10.1016/j.pec.2012.02.017
Colloca L, Benedetti F (2005) Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci 6(7):545–552. doi:10.1038/nrn1705
Colloca L, Benedetti F (2007) Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol 20(5):435–439. doi:10.1097/ACO.0b013e3282b972fb
Colloca L, Benedetti F (2009) Placebo analgesia induced by social observational learning. Pain 144(1–2):28–34. doi:10.1016/j.pain.2009.01.033
Colloca L, Lopiano L, Lanotte M, Benedetti F (2004) Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol 3(11):679–684. doi:10.1016/S1474-4422(04)00908-1
Colloca L, Sigaudo M, Benedetti F (2008a) The role of learning in nocebo and placebo effects. Pain 136(1–2):211–218. doi:10.1016/j.pain.2008.02.006
Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, Benedetti F et al (2008b) Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 139(2):306–314. doi:10.1016/j.pain.2008.04.021
Craig KD (1987) Consequences of caring: pain in the human context. Can Psychol 28:311–321
Crombez G, Van Damme S, Eccleston C (2005) Hypervigilance to pain: an experimental and clinical analysis. Pain 116(1–2):4–7. doi:10.1016/j.pain.2005.03.035
De Cosmo G, Congedo E, Lai C, Primieri P, Dottarelli A, Aceto P (2008) Preoperative psychologic and demographic predictors of pain perception and tramadol consumption using intravenous patient-controlled analgesia. Clin J Pain 24(5):399–405. doi:10.1097/AJP.0b013e3181671a08
Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J et al (2009a) Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63(4):533–543. doi:10.1016/j.neuron.2009.07.014
Eippert F, Finsterbusch J, Bingel U, Büchel C (2009b) Direct evidence for spinal cord involvement in placebo analgesia. Science 326(5951):404. doi:10.1126/science.1180142
Elsenbruch S, Kotsis V, Benson S, Rosenberger C, Reidick D, Schedlowski M et al (2012) Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain 153(2):382–390. doi:10.1016/j.pain.2011.10.036
Finniss DG, Benedetti F (2005) Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 114(1–2):3–6. doi:10.1016/j.pain.2004.12.012
Flor H (2012) New developments in the understanding and management of persistent pain. Curr Opin Psychiatry 25(2):109–113. doi:10.1097/YCO.0b013e3283503510
Fordyce WE (1976) Behavioral methods for chronic pain and illness. C.V. Mosby, St. Louis
Geers AL, Helfer SG, Weiland PE, Kosbab K (2006) Expectations and placebo response: a laboratory investigation into the role of somatic focus. J Behav Med 29(2):171–178. doi:10.1007/s10865-005-9040-5
Ip HY, Abrishami A, Peng PW, Wong J, Chung F (2009) Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology 111(3):657–677. doi:10.1097/ALN.0b013e3181aae87a
Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE et al (2008) Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336(7651):999–1003. doi:10.1136/bmj.39524.439618.25
Khan RS, Ahmed K, Blakeway E, Skapinakis P, Nihoyannopoulos L, Macleod K et al (2011) Catastrophizing: a predictive factor for postoperative pain. Am J Surg 201(1):122–131. doi:10.1016/j.amjsurg.2010.02.007
Kirsch I (1997) Specifying nonspecifics: psychological mechanisms of placebo effects. In: Harrington A (ed) The placebo effect: an interdisciplinary exploration. Cambridge University Press, Cambridge, MA, pp 166–186
Kirsch I, Lynn SJ, Vigorito M, Miller RR (2004) The role of cognition in classical and operant conditioning. J Clin Psychol 60(4):369–392. doi:10.1002/jclp.10251
Klinger R, Soost S, Flor H, Worm M (2007) Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain 128(1–2):31–39. doi:10.1016/j.pain.2006.08.025
Levine JD, Gordon NC, Fields HL (1978) The mechanism of placebo analgesia. Lancet 2(8091):654–657
Lyby PS, Forsberg JT, Asli O, Flaten MA (2012) Induced fear reduces the effectiveness of a placebo intervention on pain. Pain 153(5):1114–1121. doi:10.1016/j.pain.2012.02.042
Millan MJ (2002) Descending control of pain. Prog Neurobiol 66(6):355–474
Moseley GL, Nicholas MK, Hodges PW (2004) A randomized controlled trial of intensive neurophysiology education in chronic low back pain. Clin J Pain 20(5):324–330
Nakamura Y, Donaldson GW, Kuhn R, Bradshaw DH, Jacobson RC, Chapman CR (2012) Investigating dose-dependent effects of placebo analgesia: a psychophysiological approach. Pain 153(1):227–237. doi:10.1016/j.pain.2011.10.024
Pavlin DJ, Sullivan MJ, Freund PR, Roesen K (2005) Catastrophizing: a risk factor for postsurgical pain. Clin J Pain 21(1):83–90
Petrovic P, Kalso E, Petersson KM, Ingvar M (2002) Placebo and opioid analgesia– imaging a shared neuronal network. Science 295(5560):1737–1740. doi:10.1126/science.1067176
Price DD (1997) The contribution of desire and expectation to placebo analgesia: implications for new research strategies. In: Harrington A (ed) The placebo effect. An interdisciplinary exploration. Harvard University Press, Cambridge
Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS (1999) An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83(2):147–156
Price DD, Finniss DG, Benedetti F (2008) A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59:565–590. doi:10.1146/annurev.psych.59.113006.095941
Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2007) Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55(2):325–336. doi:10.1016/j.neuron.2007.06.028
Świder K, Bąbel P (2013) The effect of the sex of a model on nocebo hyperalgesia induced by social observational learning. Pain 154(8):1312–1317. doi:10.1016/j.pain.2013.04.001S0304-3959(13)00155-3 [pii]
Taenzer P, Melzack R, Jeans ME (1986) Influence of psychological factors on postoperative pain, mood and analgesic requirements. Pain 24(3):331–342
Tracey I, Mantyh PW (2007) The cerebral signature for pain perception and its modulation. Neuron 55(3):377–391. doi:10.1016/j.neuron.2007.07.012
Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE (1994) The importance of placebo effects in pain treatment and research. JAMA 271(20):1609–1614
Van Damme S, Legrain V, Vogt J, Crombez G (2010) Keeping pain in mind: a motivational account of attention to pain. Neurosci Biobehav Rev 34(2):204–213. doi:10.1016/j.neubiorev.2009.01.005
Vase L, Robinson ME, Verne GN, Price DD (2003) The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 105(1–2):17–25
Vögtle E, Barke A, Kröner-Herwig B (2013) Nocebo hyperalgesia induced by social observational learning. Pain 154(8):1427–1433. doi:10.1016/j.pain.2013.04.041S0304-3959(13)00196-6 [pii]
Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ et al (2004) Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303(5661):1162–1167. doi:10.1126/science.1093065
Wager TD, Scott DJ, Zubieta JK (2007) Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci USA 104(26):11056–11061. doi:10.1073/pnas.0702413104
Wall PD (1999) Textbook of pain. Churchill Livingston, Edinburgh
Watson A, El-Deredy W, Iannetti GD, Lloyd D, Tracey I, Vogt BA et al (2009) Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception. Pain 145(1–2):24–30. doi:10.1016/j.pain.2009.04.003
Weisenberg M, Schwarzwald J, Tepper I (1996) The influence of warning signal timing and cognitive preparation on the aversiveness of cold-pressor pain. Pain 64(2):379–385
Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA et al (2005) Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25(34):7754–7762. doi:10.1523/JNEUROSCI.0439-05.2005
Acknowledgments
This research was funded by grants by the Deutsche Forschungsgemeinschaft (FOR 1328/1) to R.K. (Kl 1350/3-1) and H.F. (Fl 156/33-1).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Klinger, R., Flor, H. (2014). Clinical and Ethical Implications of Placebo Effects: Enhancing Patients’ Benefits from Pain Treatment. In: Benedetti, F., Enck, P., Frisaldi, E., Schedlowski, M. (eds) Placebo. Handbook of Experimental Pharmacology, vol 225. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44519-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-44519-8_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44518-1
Online ISBN: 978-3-662-44519-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)